Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & EquivalentsCommon EquityCurrent AssetsGoodwillGoodwill & IntangiblesLiabilities and Shareholders EquityNon-Current AssetsOther Non-Current LiabilitiesPayablesPreferred Stock LiabilitiesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)Retained EarningsShareholder's EquityShares OutstandingTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Income from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersOperating ExpensesOperating IncomeOther Non Operating IncomeProfit After TaxResearch & DevelopmentSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Machine, Furnitures, Fixtures & OtherOther Gross PP&E AdjustmentsOther Gross PP&E AdjustmentsShares IssuedShares OutstandingShares Outstanding
Ratios

Minerva Neurosciences (NERV) Shares Outstanding (2016 - 2026)

Minerva Neurosciences filings provide 3 years of Shares Outstanding readings, the most recent being $5.3 million for Q4 2021.

  • On a quarterly basis, Shares Outstanding changed 0.0% to $5.3 million in Q4 2021 year-over-year; TTM through Dec 2021 was $5.3 million, a 0.0% change, with the full-year FY2021 number at $5.3 million, changed 0.0% from a year prior.
  • Shares Outstanding hit $5.3 million in Q4 2021 for Minerva Neurosciences, roughly flat from $5.3 million in the prior quarter.
  • In the past five years, Shares Outstanding ranged from a high of $42.7 million in Q3 2020 to a low of $5.3 million in Q4 2020.
  • Median Shares Outstanding over the past 3 years was $5.3 million (2020), compared with a mean of $20.9 million.
  • The widest YoY moves for Shares Outstanding: up 0.0% in 2021, down 87.49% in 2021.
  • Minerva Neurosciences' Shares Outstanding stood at $39.1 million in 2019, then crashed by 86.34% to $5.3 million in 2020, then changed by 0.0% to $5.3 million in 2021.
  • The last three reported values for Shares Outstanding were $5.3 million (Q4 2021), $5.3 million (Q3 2021), and $5.3 million (Q2 2021) per Business Quant data.